The non-structural 5A protein of hepatitis C virus exhibits genotypic differences in interferon antagonism

Journal of Hepatology

Volumn 49, Issue 6, 2008, Pages 899-907

  Tsai, Ya Hui ^a   Kuang, Wan Fen ^b   Lu, Tsai Yi ^a   Kao, Jia Horng ^b   Lai, Ming Yang ^a   Liu, Chun Jen ^a   Chen, Pei Jer ^a   Hwang, Lih Hwa ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Genotype; Hepatitis C virus; IFN antagonism; NS5A

Indexed keywords

INTERFERON; NONSTRUCTURAL PROTEIN 5A; VASOPRESSIN V3 RECEPTOR;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL LINE; CULTURE MEDIUM; DRUG ACTIVITY; DRUG SENSITIVITY; GENETIC RESISTANCE; GENOTYPE; HELA CELL; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TREATMENT RESPONSE; VERO CELL; VIRUS REPLICATION;

EID: 84984559137     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.06.030     Document Type: Article

References (25)

1. Di Bisceglie A.M., and Hoofnagle J.H. Optimal therapy of hepatitis C. Hepatology 36 (2002) S121-S127
2. Pawlotsky J.M. Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C. Antiviral Res 59 (2003) 1-11
3. Poynard T., Yuen M.F., Ratziu V., and Lai C.L. Viral hepatitis C. Lancet 362 (2003) 2095-2100
4. Samuel C.E. Antiviral actions of interferons. Clin Microbiol Rev 14 (2001) 778-809
5. Katze M.G., He Y., and Gale Jr. M. Viruses and interferon: a fight for supremacy. Nat Rev Immunol 2 (2002) 675-687
6. Mbow M.L., and Sarisky R.T. What is disrupting IFN-alpha's antiviral activity?. Trends Biotechnol 22 (2004) 395-399
7. Gale Jr. M., and Foy E.M. Evasion of intracellular host defence by hepatitis C virus. Nature 436 (2005) 939-945
8. Thimme R., Lohmann V., and Weber F. A target on the move: innate and adaptive immune escape strategies of hepatitis C virus. Antiviral Res 69 (2006) 129-141
9. Enomoto N., Sakuma I., Asahina Y., Kurosaki M., Murakami T., Yamamoto C., et al. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J Clin Invest 96 (1995) 224-230
10. Gale Jr. M., Blakely C.M., Kwieciszewski B., Tan S.L., Dossett M., Tang N.M., et al. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol Cell Biol 18 (1998) 5208-5218
11. Gale Jr. M.J., Korth M.J., Tang N.M., Tan S.L., Hopkins D.A., Dever T.E., et al. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230 (1997) 217-227
12. Polyak S.J., Paschal D.M., McArdle S., Gale Jr. M.J., Moradpour D., and Gretch D.R. Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication. Hepatology 29 (1999) 1262-1271
13. Podevin P., Sabile A., Gajardo R., Delhem N., Abadie A., Lozach P.Y., et al. Expression of hepatitis C virus NS5A natural mutants in a hepatocytic cell line inhibits the antiviral effect of interferon in a PKR-independent manner. Hepatology 33 (2001) 1503-1511
14. Francois C., Duverlie G., Rebouillat D., Khorsi H., Castelain S., Blum H.E., et al. Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis. J Virol 74 (2000) 5587-5596
15. Hallum J.V., Thacore H.R., and Youngner J.S. Factors affecting the sensitivity of different viruses to interferon. J Virol 6 (1970) 156-162
16. Stewart II W.E., Scott W.D., and Sulkin S.E. Relative sensitivities of viruses to different species of interferon. J Virol 4 (1969) 147-153
17. Cheney I.W., Lai V.C., Zhong W., Brodhag T., Dempsey S., Lim C., et al. Comparative analysis of anti-hepatitis C virus activity and gene expression mediated by alpha, beta, and gamma interferons. J Virol 76 (2002) 11148-11154
18. Guo J.T., Zhu Q., and Seeger C. Cytopathic and noncytopathic interferon responses in cells expressing hepatitis C virus subgenomic replicons. J Virol 77 (2003) 10769-10779
19. Makarova O., Kamberov E., and Margolis B. Generation of deletion and point mutations with one primer in a single cloning step. Biotechniques 29 (2000) 970-972
20. Macdonald A., and Harris M. Hepatitis C virus NS5A: tales of a promiscuous protein. J Gen Virol 85 (2004) 2485-2502
21. Reyes G.R. The nonstructural NS5A protein of hepatitis C virus: an expanding, multifunctional role in enhancing hepatitis C virus pathogenesis. J Biomed Sci 9 (2002) 187-197
22. Inchauspe G., Zebedee S., Lee D.H., Sugitani M., Nasoff M., and Prince A.M. Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates. Proc Natl Acad Sci USA 88 (1991) 10292-10296
23. Duverlie G., Khorsi H., Castelain S., Jaillon O., Izopet J., Lunel F., et al. Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity. J Gen Virol 79 (1998) 1373-1381
24. Feld J.J., and Hoofnagle J.H. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature 436 (2005) 967-972
25. Neumann A.U., Lam N.P., Dahari H., Davidian M., Wiley T.E., Mika B.P., et al. Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virus. J Infect Dis 182 (2000) 28-35